Based on data from the past 90 days ending January 10, 2026, Immunovant's three largest insider shareholders are Director Sciences Ltd. Roivant (113.32Mn shares), Chief Executive Officer Peter Salzmann (1.18Mn shares), Director Frank Torti (835.04K shares).
| Holder | Position | Shares | Report Date |
|---|---|---|---|
| Sciences Ltd. Roivant | 113,317,007 | 12 Dec, 2025 | |
| Peter Salzmann | Chief Executive Officer | 1,178,191 | 17 Apr, 2025 |
| Frank Torti | 835,039 | 03 Apr, 2025 | |
| Julia G. Butchko | Chief Development Officer | 440,959 | 23 Aug, 2024 |
| Eva Renee Barnett | Chief Financial Officer | 396,774 | 17 Apr, 2025 |
| William L. Macias | Chief Medical Officer | 357,353 | 21 Feb, 2025 |
| Mark S. Levine | Chief Legal Officer | 319,228 | 22 Nov, 2024 |
| Michael Geffner | Chief Medical Officer | 217,958 | 24 Oct, 2025 |
| Tiago Girao | Chief Financial Officer | 208,388 | 05 May, 2025 |
| Jay S Stout | Chief Technology Officer | 199,611 | 09 Jan, 2026 |
| Melanie Gloria | Chief Operating Officer | 173,511 | 21 Nov, 2025 |
| Tuyl Christopher Van | Chief Legal Officer | 149,930 | 19 Dec, 2025 |
| George V Migausky | 137,251 | 03 Apr, 2025 | |
| Atul Pande | 122,851 | 03 Apr, 2025 | |
| Douglas J. Hughes | 120,773 | 03 Dec, 2025 | |
| Andrew J. Fromkin | 85,852 | 03 Dec, 2025 | |
| Jake Bauer | 25,016 | 05 May, 2025 | |
| Robert Graham Susman | 25,016 | 05 May, 2025 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 07 Jan, 2026 | Jay S Stout | Common Stock | D | 1,148 | $26.51 | 199,666 | D | S |
| 07 Jan, 2026 | Jay S Stout | Common Stock | D | 55 | $26.92 | 199,611 | D | S |
| 18 Dec, 2025 | Tuyl Christopher Van | Common Stock | D | 2,284 | $27.38 | 149,930 | D | S |
| 18 Dec, 2025 | Tuyl Christopher Van | Common Stock | D | 8,529 | $26.78 | 152,214 | D | S |
| 18 Dec, 2025 | Tuyl Christopher Van | - | - | 149,930 | D | |||
| 18 Dec, 2025 | Tuyl Christopher Van | - | - | 152,214 | D | |||
| 12 Dec, 2025 | Sciences Ltd. Roivant | Common Stock, $0.0001 par value per share | A | 16,666,666 | $21.00 | 113,317,007 | D | P |
| 12 Dec, 2025 | Sciences Ltd. Roivant | - | - | 113,317,007 | D | |||
| 01 Dec, 2025 | Andrew J. Fromkin | - | - | 88,750 | D | |||
| 01 Dec, 2025 | Andrew J. Fromkin | - | - | 85,852 | D | |||
| 01 Dec, 2025 | Andrew J. Fromkin | Common Stock | D | 2,898 | $23.95 | 85,852 | D | S |
| 01 Dec, 2025 | Andrew J. Fromkin | Common Stock | D | 19,351 | $23.14 | 88,750 | D | S |
| 01 Dec, 2025 | Douglas J. Hughes | Common Stock | D | 13,091 | $23.14 | 122,682 | D | S |
| 01 Dec, 2025 | Douglas J. Hughes | Common Stock | D | 1,909 | $23.96 | 120,773 | D | S |
| 20 Nov, 2025 | Melanie Gloria | - | - | 173,511 | D | |||
| 20 Nov, 2025 | Melanie Gloria | Common Stock | D | 2,375 | $23.97 | 173,511 | D | S |
| 20 Nov, 2025 | Melanie Gloria | - | - | 175,886 | D | |||
| 20 Nov, 2025 | Melanie Gloria | Common Stock | D | 10,251 | $23.54 | 175,886 | D | S |
| 22 Oct, 2025 | Jay S Stout | Common Stock | D | 2,520 | $19.03 | 200,814 | D | S |
| 22 Oct, 2025 | Michael Geffner | Common Stock | D | 2,595 | $19.03 | 217,958 | D | S |